The total return over the past 12 months is -24.38% vs. +16.94% for the S&P 500. So far it's up -5.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (24.38%) | (79.20%) | (78.37%) | N/A | N/A | N/A |
| Total Return CAGR | (24.38%) | (79.20%) | (78.37%) | N/A | N/A | N/A |
| Revenue CAGR | +10.03% | (1.43%) | +17.97% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bionano Genomics, Inc. (BNGO)
| Year | Start price | End price | BNGO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.53 | $1.45 | (5.23%) | +14.51% | (19.74%) |
| 2025 | $17.30 | $1.53 | (91.16%) | +17.72% | (108.88%) |
| 2024 | $113.40 | $17.30 | (84.74%) | +24.89% | (109.63%) |
| 2023 | $876.00 | $113.40 | (87.05%) | +26.19% | (113.24%) |
| 2022 | $1,794.00 | $876.00 | (51.17%) | (18.17%) | (33.00%) |
| 2021 | $1,848.00 | $1,794.00 | (2.92%) | +28.74% | (31.66%) |
| 2020 | $744.00 | $1,848.00 | +148.39% | +18.37% | +130.02% |
| 2019 | $3,143.99 | $744.00 | (76.34%) | +31.22% | (107.56%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
